Quantcast

CME Outfitters Announces New neuroscienceCME Webcast: ‘Early Assessment and Multimodal Therapy for MS-Associated Cognitive Dysfunction’

October 20, 2010

Offered as a simultaneous webcast and telephone audioconference premiering Tuesday, November 9, 2010, from 12:00 p.m.-1:00 p.m. ET, the continuing education activity seeks to implement strategies to improve assessment and management of cognitive dysfunction in patients with multiple sclerosis.

Rockville, MD (PRWEB) October 19, 2010

CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), is pleased to announce an upcoming neuroscienceCME Webcast titled “Early Assessment and Multimodal Therapy for MS-Associated Cognitive Dysfunction.”

Offered as a simultaneous webcast and telephone audioconference premiering Tuesday, November 9, 2010, from 12:00 p.m.-1:00 p.m. ET, the continuing education activity seeks to implement strategies to improve assessment and management of cognitive dysfunction in patients with multiple sclerosis. This CE activity will also be available as an archived webcast, podcast, and teleconference shortly after the live webcast.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR504 and click the Register for Live Webcast icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR504, print and complete the activity details form, and fax to 614.929.3600.

Statement of Need:
Cognitive impairment is common in multiple sclerosis (MS), occurs at all stages of the disease, and can be a major source of disability, social impairment, and impoverished quality of life. Even when physical disability is minimal, patients with MS are still at high risk for developing cognitive impairment. Neuropsychological assessment””including recognizing common comorbidities such as fatigue and depression””is essential when diagnosing cognitive dysfunction.

As cognition is increasingly recognized as a major feature of MS, physicians need education that will increase confidence in their ability to provide patients with accurate assessment, rehabilitation, and management. An integration of both pharmacological and nonpharmacological treatments may play an increasing role in the optimal management and targeting of cognitive deficits.

This neuroscienceCME Webcast will provide clinicians with an opportunity to evaluate the latest evidence surrounding assessment and potential management of cognitive dysfunction in patients with MS with a goal of improving patients’ health-related quality of life.

Faculty:
Michael Racke, MD (Moderator)
Professor and Chairman in Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
Ohio State University Medical Center
Columbus, OH

Ralph H. B. Benedict, PhD
Professor of Neurology, Psychiatry, and Psychology
Jacobs Neurological Institute
State University of New York Buffalo School of Medicine and Biomedical Sciences
Buffalo General Hospital
Buffalo, NY

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Define the quality of life (QOL) effects of cognitive dysfunction in multiple sclerosis (MS).
  • Apply techniques for neuropsychological assessment of cognitive impairment to facilitate early and accurate diagnosis of cognitive dysfunction in multiple sclerosis (MS).
  • Compare and contrast pharmacological and nonpharmacological therapies for the treatment of cognitive dysfunction in MS, then translate that knowledge into improved, individualized therapy for patients.

Target Audience:
The activity is designed for physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other healthcare professionals with an interest in multiple sclerosis.

Financial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from Biogen Idec in support of this CE activity.

Credit Information:
The activity offers CE credit for:

  • Physicians (ACCME/AMA PRA Category 1â“¢)
  • Nurses (CNE)
  • Pharmacists (ACPE)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Wednesday, November 9, 2011

Post-tests, credit request forms, and activity evaluations must be completed online at neuroscienceCME.com (click on the Testing/Certification link under the Activities tab–requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site’s primary mission is to be the professional’s central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compassâ“¢, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on “Subscribe to Clinical Compassâ“¢.”

Contact: Rachel Ellis
CME Outfitters, LLC
614.328.4506 direct
614.929.3600 fax

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2010/10/prweb4661104.htm


Source: prweb



comments powered by Disqus